Nature Communications (Oct 2022)

A scalable platform to discover antimicrobials of ribosomal origin

  • Richard S. Ayikpoe,
  • Chengyou Shi,
  • Alexander J. Battiste,
  • Sara M. Eslami,
  • Sangeetha Ramesh,
  • Max A. Simon,
  • Ian R. Bothwell,
  • Hyunji Lee,
  • Andrew J. Rice,
  • Hengqian Ren,
  • Qiqi Tian,
  • Lonnie A. Harris,
  • Raymond Sarksian,
  • Lingyang Zhu,
  • Autumn M. Frerk,
  • Timothy W. Precord,
  • Wilfred A. van der Donk,
  • Douglas A. Mitchell,
  • Huimin Zhao

DOI
https://doi.org/10.1038/s41467-022-33890-w
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 15

Abstract

Read online

Ribosomally synthesized and post-translationally modified peptides are a source of antimicrobials. Here, the authors report a platform for the rapid evaluation and characterization of biosynthetic gene clusters that enables the identification of 30 structurally diverse modified peptides, including three showing antimicrobial activities.